• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug approval

Traffic light go start restart green light
Pharma

Mirum scores FDA approval for ultra-rare disorder

Rare disease pharma Mirum scored an approval for its ultra-rare bone lesion treatment it bought from Incyte.
Donavyn Coffey Sep 25, 2026 4:10pm
checkered flag finish line racecar

In landmark for Korean biotech, Elevar wins FDA nod for Lyrfigtu

Sep 24, 2026 11:25am
FDA approved stamp regulations yes go

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Sep 17, 2026 2:06pm
Takeda

Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo

Aug 28, 2026 10:04pm
Bixlenvo

Gilead crosses FDA finish line with new HIV combo pill

Aug 27, 2026 5:56pm
BMS

BMS bags first FDA approval for CELMoD franchise with Zenbexus

Aug 14, 2026 10:09am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings